Labviva just moved. Here's exactly what to do next.
Who to reach, what to say, and why now — on Labviva, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Contract Type
partnership
BostonInformation TechnologyBiotechnologyDescription
Labviva has announced the close of its $25 million Series B funding, bringing its total funding to $55 million. The investment, led by 53 Stations, Biospring Partners, B Capital Group, and Glasswing Ventures, will be used to accelerate new product development, bolster marketing and customer support, and expand internationally. The partnership with 53 Station’s Co-Founder and Managing Partner, Jason Pritzker, reflects Labviva’s booming growth and escalating demand in Biopharma for automated supply chain and procurement solutions.